Cargando…
Changing Treatment May Affect the Predictive Ability of European Treatment Outcome Study Scoring for the Prognosis of Patients with Chronic Myeloid Leukemia
OBJECTIVE: Previous studies compared the predictive ability of the European Treatment Outcome Study (EUTOS), Sokal, and Hasford scoring systems and demonstrated inconsistent findings with unknown reasons. This study was conducted to determine a useful scoring system to predict the prognosis of patie...
Autores principales: | Huang, Jing, Wang, Leyan, Chen, Lu, Qun, He, Yajing, Xu, Fangping, Chen, Xielan, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451668/ https://www.ncbi.nlm.nih.gov/pubmed/27751981 http://dx.doi.org/10.4274/tjh.2016.0156 |
Ejemplares similares
-
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients
por: Yamamoto, Eri, et al.
Publicado: (2014) -
Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy
por: Narang, Neha Chopra, et al.
Publicado: (2017) -
High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions
por: Fu, Lin, et al.
Publicado: (2017) -
Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
por: Wang, Suwei, et al.
Publicado: (2019) -
Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
por: Goldman, Samantha L., et al.
Publicado: (2019)